Skip to main content
. 2021 Apr 19;12:641848. doi: 10.3389/fphar.2021.641848

FIGURE 7.

FIGURE 7

Tanshinone IIA regulated NF-κB signaling pathway in BV2 cells after oxygen-glucose deprivation (OGD). (A) The protein level of p-IκB in BV2 cells treated with Tanshinone IIA. (B) The protein level of p-p65 in BV2 cells treated with Tanshinone IIA. (C) The protein level of p-IκB in BV2 cells treated with BAY-11-7082. (D) The protein level of p-p65 in BV2 cells treated with Tanshinone IIA and BAY-11–7082. ##p < 0.01, compared with the control group. *p < 0.05, **p < 0.01, compared with the OGD group. Con, control group; OGD, oxygen-glucose deprivation; TanIIA, Tanshinone IIA; BAY, BAY-11-7082, a NF-κB inhibitor, n = 3.